Received May 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (DAPTACEL) | SANOFI PASTEUR | 1 | 2CA77C1 | IM / LL |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 9R5LC | IM / RL |
| PNC13 | PNEUMO (PREVNAR13) | PFIZER\WYETH | 1 | GK5782 | IM / LL |
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | YL9YN | PO / MO |
This is not adverse reaction event. HAVRIX was administered by 11/04/2024, the Hep-A vaccine expired by 11/02/2024. It's administered 2 days later after expired. And we already report to GSK and authority on 11/05/2024. But report in VAERS, because it reported by GSK, so we report it again. We already followed the results from GSK and authority. This is duplicated report. There is no adverse reaction by vaccination and no treatment at all. Informed to patient's parents right a way.
No
None
None
None
None tests.